-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Only for medical professionals to read and refer to clinical information, 1s reach Obesity refers to the body's excessive total fat content and/or local fat content increase and abnormal distribution.
It is a chronic metabolic disease caused by the combination of genetic and environmental factors
.
Obesity has become a global "epidemic", and the average body mass index (BMI) of the global population is gradually increasing [1]
.
Patients with one of obesity-related complications such as hyperglycemia, hypertension, dyslipidemia, non-alcoholic fatty liver disease (NAFLD), weight-bearing joint pain, sleep apnea syndrome, etc.
, recommend the use of drugs based on life>
.
Source: Screenshot from the literature.
Recently, Qingyang Shi et al.
published a paper in The Lancet.
The study compared the effects of different weight-loss drugs under different treatment options on the treatment of overweight and The safety and effectiveness of obese patients [2]
.
Let's take a look at today's newsletter! Want to see more previous issues of "Top Journal Essentials"? Go to the "Clinical Assistant in the Medical Field" service account to have a look! 1.
Click on the business card below to follow the official account of "Clinical Assistant in the Medical Field" 2.
Find the "Top Journal Essentials" in the menu bar 3.
View the latest journals in each subject area 4.
You can also click on "Subscription Settings" 5.
Subscribe to the subject area you follow Subscribe to the daily push of the subject and read a new top issue every day! Let's use such an easy-to-use tool! References: [1].
Working Group on Obesity in China.
Guidelines for Prevention and Control of Overweight and Obesity in Chinese Adults (Excerpt)[J].
Journal of Nutrition,2004(01):1-4.
[2].
Shi Q,Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, Sun F, Li L, Yu J, Nong K, Zou X, Zhu S, Wang C, Zhang S, Qiao Z, Jian Z, Li Y, Zhang X, Chen K, Qu F, Wu Y, He Y, Tian H, Li S.
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials .
Lancet.
2021 Dec 8:S0140-6736(21)01640-8.
doi:10.
1016/S0140-6736(21)01640-8.
Epub ahead of print.
PMID:34895470.
Source of this article: Clinical assistant in the medical field Author of this article: Responsible editor of Jie Xiaoyao: Xiaodangdang Sun Ying, the medical community strives for the accuracy and reliability of its published content when it is reviewed and approved, but does not make any comments on the timeliness of the published content and the accuracy and completeness of the cited information (if any).
Any promises and guarantees, and do not assume any responsibilities caused by the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
It is a chronic metabolic disease caused by the combination of genetic and environmental factors
.
Obesity has become a global "epidemic", and the average body mass index (BMI) of the global population is gradually increasing [1]
.
Patients with one of obesity-related complications such as hyperglycemia, hypertension, dyslipidemia, non-alcoholic fatty liver disease (NAFLD), weight-bearing joint pain, sleep apnea syndrome, etc.
, recommend the use of drugs based on life>
.
Source: Screenshot from the literature.
Recently, Qingyang Shi et al.
published a paper in The Lancet.
The study compared the effects of different weight-loss drugs under different treatment options on the treatment of overweight and The safety and effectiveness of obese patients [2]
.
Let's take a look at today's newsletter! Want to see more previous issues of "Top Journal Essentials"? Go to the "Clinical Assistant in the Medical Field" service account to have a look! 1.
Click on the business card below to follow the official account of "Clinical Assistant in the Medical Field" 2.
Find the "Top Journal Essentials" in the menu bar 3.
View the latest journals in each subject area 4.
You can also click on "Subscription Settings" 5.
Subscribe to the subject area you follow Subscribe to the daily push of the subject and read a new top issue every day! Let's use such an easy-to-use tool! References: [1].
Working Group on Obesity in China.
Guidelines for Prevention and Control of Overweight and Obesity in Chinese Adults (Excerpt)[J].
Journal of Nutrition,2004(01):1-4.
[2].
Shi Q,Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, Sun F, Li L, Yu J, Nong K, Zou X, Zhu S, Wang C, Zhang S, Qiao Z, Jian Z, Li Y, Zhang X, Chen K, Qu F, Wu Y, He Y, Tian H, Li S.
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials .
Lancet.
2021 Dec 8:S0140-6736(21)01640-8.
doi:10.
1016/S0140-6736(21)01640-8.
Epub ahead of print.
PMID:34895470.
Source of this article: Clinical assistant in the medical field Author of this article: Responsible editor of Jie Xiaoyao: Xiaodangdang Sun Ying, the medical community strives for the accuracy and reliability of its published content when it is reviewed and approved, but does not make any comments on the timeliness of the published content and the accuracy and completeness of the cited information (if any).
Any promises and guarantees, and do not assume any responsibilities caused by the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
